France Generics Market Summary, Competitive Analysis and Forecast to 2027
Summary
Generics in France industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices.
- The French generics market had total revenues of $4.2 billion in 2022, representing a compound annual growth rate (CAGR) of 2.8% between 2017 and 2022.
- Market consumption volume increased with a CAGR of 1.3% between 2017 and 2022, to reach a total of 86.1% in 2022.
- Factors such as accelerating healthcare costs, growing consumer price inflation, rising expiration of patents for branded medicines, and growing first generic drug approvals are driving the generics market. According to in-house research, in 2022, the consumer price inflation-health in France reached 0.8%.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in France
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in France
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the France generics market with five year forecasts
- What was the size of the France generics market by value in 2022?
- What will be the size of the France generics market in 2027?
- What factors are affecting the strength of competition in the France generics market?
- How has the market performed over the last five years?
- What are the main segments that make up France's generics market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Market volume
- 1.4. Market volume forecast
- 1.5. Geography segmentation
- 1.6. Market rivalry
- 1.7. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 3.2. Market volume
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 5.2. Market volume forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strengths of the leading players?
- 7.3. Have there been any recent developments in the market?
- 8 Company Profiles
- 8.1. Teva Pharmaceutical Industries Limited
- 8.2. Pfizer Inc.
- 8.3. Sanofi SA
- 8.4. Les Laboratoires Servier
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: France generics market value: $ million, 2017-22
- Table 2: France generics market volume: %, 2017-22
- Table 3: France generics market geography segmentation: $ million, 2022
- Table 4: France generics market value forecast: $ million, 2022-27
- Table 5: France generics market volume forecast: %, 2022-27
- Table 6: Teva Pharmaceutical Industries Limited: key facts
- Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
- Table 8: Teva Pharmaceutical Industries Limited: Key Employees
- Table 9: Pfizer Inc.: key facts
- Table 10: Pfizer Inc.: Annual Financial Ratios
- Table 11: Pfizer Inc.: Key Employees
- Table 12: Pfizer Inc.: Key Employees Continued
- Table 13: Sanofi SA: key facts
- Table 14: Sanofi SA: Annual Financial Ratios
- Table 15: Sanofi SA: Key Employees
- Table 16: Sanofi SA: Key Employees Continued
- Table 17: Les Laboratoires Servier: key facts
- Table 18: Les Laboratoires Servier: Key Employees
- Table 19: France size of population (million), 2018-22
- Table 20: France gdp (constant 2005 prices, $ billion), 2018-22
- Table 21: France gdp (current prices, $ billion), 2018-22
- Table 22: France inflation, 2018-22
- Table 23: France consumer price index (absolute), 2018-22
- Table 24: France exchange rate, 2018-22
- List of Figures
- Figure 1: France generics market value: $ million, 2017-22
- Figure 2: France generics market volume: %, 2017-22
- Figure 3: France generics market geography segmentation: % share, by value, 2022
- Figure 4: France generics market value forecast: $ million, 2022-27
- Figure 5: France generics market volume forecast: %, 2022-27
- Figure 6: Forces driving competition in the generics market in France, 2022
- Figure 7: Drivers of buyer power in the generics market in France, 2022
- Figure 8: Drivers of supplier power in the generics market in France, 2022
- Figure 9: Factors influencing the likelihood of new entrants in the generics market in France, 2022
- Figure 10: Factors influencing the threat of substitutes in the generics market in France, 2022
- Figure 11: Drivers of degree of rivalry in the generics market in France, 2022
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook